Patents by Inventor Steven A. Bender

Steven A. Bender has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240093793
    Abstract: A fluid transfer system includes a valve tree, the valve tree having a master valve having a flow axis and a header. The fluid transfer system further includes a coupler disposed between, connected to, and in fluid communication with, the valve tree and the header. The coupler has a fixed length and includes a coupler multi-path flow connector in fluid communication with the valve tree. The coupler also includes a flow control valve having a flow axis, the flow control valve directly coupled to the coupler multi-path flow connector and in fluid communication with the header.
    Type: Application
    Filed: November 29, 2023
    Publication date: March 21, 2024
    Inventors: Chad BABINEAUX, Scott BENDER, Steven BENDER, Jerod BUSHMAN, Jason CADE, Brenton J. GRESKA
  • Publication number: 20240092918
    Abstract: This application discloses anti-CCR7 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
    Type: Application
    Filed: February 3, 2023
    Publication date: March 21, 2024
    Inventors: Steven BENDER, Tracy CHARLTON, Anna GALKIN, Bernhard Hubert GEIERSTANGER, Scott Martin GLASER, Shailaja KASIBHATLA, Mark KNUTH, Sabine ROTTMANN, Sarah RUE, Glen SPRAGGON, Tetsuo UNO
  • Patent number: 11634497
    Abstract: This application discloses anti-CCR7 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: April 25, 2023
    Assignee: NOVARTIS AG
    Inventors: Steven Bender, Tracy Charlton, Anna Galkin, Bernhard Hubert Geierstanger, Scott Martin Glaser, Shailaja Kasibhatla, Mark Knuth, Sabine Rottmann, Sarah Rue, Glen Spraggon, Tetsuo Uno
  • Publication number: 20230053449
    Abstract: Provided herein are antibodies to DC-SIGN, conjugates of DC-SiGN antibodies, and DC-SiGN antibody fusion proteins and the use of such antibodies, conjugates, and fusion proteins for the treatment of diseases such as cancer.
    Type: Application
    Filed: October 30, 2019
    Publication date: February 23, 2023
    Inventors: Lisa BARNETT, Steven BENDER, Alex Cortez, Sarah COX, Jonathan DEANE, Scott Martin GLASER, Ben WEN, Tom Yao-Hsiang WU
  • Patent number: 11536370
    Abstract: The present disclosure provides an improved bellows type seal. In the present disclosure, the bellows of the seal dampen resulting in the seal having a longer useful life and can withstand higher loads. The seal includes a damper assembly that includes a spring and a band that are engaged on the exterior of a bellows for dampening vibrations.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: December 27, 2022
    Assignee: Eaton Intelligent Power Limited
    Inventors: Steven Bender, Jeffrey Lavin
  • Publication number: 20210170043
    Abstract: Provided herein are immunoconjugates comprising an anti-DC-SIGN antibody conjugated to a STING agonist. Also disclosed are methods of making the immunoconjugates and methods of treating cancer using the immunoconjugates.
    Type: Application
    Filed: October 30, 2019
    Publication date: June 10, 2021
    Inventors: Lisa BARNETT, Steven BENDER, Charles Y. CHO, Sarah COX, Jonathan Deane, Scott Martin GLASER, Xueshi Hao, Shailaja KASIBHATLA, Weijia OU, Tetsuo UNO, Yongqin WAN, Ben WEN, Tom Yao-Hsiang WU
  • Publication number: 20210156472
    Abstract: The present disclosure provides an improved bellows type seal. In the present disclosure, the bellows of the seal dampen resulting in the seal having a longer useful life and can withstand higher loads. The seal includes a damper assembly that includes a spring and a band that are engaged on the exterior of a bellows for dampening vibrations.
    Type: Application
    Filed: November 20, 2020
    Publication date: May 27, 2021
    Inventors: Steven Bender, Jeffrey Lavin
  • Publication number: 20200216548
    Abstract: This application discloses anti-CCR7 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
    Type: Application
    Filed: February 1, 2018
    Publication date: July 9, 2020
    Inventors: Steven BENDER, Tracy CHARLTON, Anna GALKIN, Bernhard Hubert GEIERSTANGER, Scott Martin GLASER, Shailaja KASIBHATLA, Mark KNUTH, Sabine ROTTMANN, Sarah RUE, Glen SPRAGGON, Tetsuo UNO
  • Publication number: 20200208747
    Abstract: A fluid transfer system includes a valve tree, the valve tree having a master valve having a flow axis and a header. The fluid transfer system further includes a coupler disposed between, connected to, and in fluid communication with, the valve tree and the header. The coupler has a fixed length and includes a coupler multi-path flow connector in fluid communication with the valve tree. The coupler also includes a flow control valve having a flow axis, the flow control valve directly coupled to the coupler multi-path flow connector and in fluid communication with the header.
    Type: Application
    Filed: September 11, 2019
    Publication date: July 2, 2020
    Inventors: Chad BABINEAUX, Scott BENDER, Steven BENDER, Jerod BUSHMAN, Jason CADE, Brenton J. GRESKA, Glenn C. PARKS, JR.
  • Publication number: 20080034218
    Abstract: A user recognition and identification system and method to identify keyboard users. Key text is evaluated against previously recorded keystrokes by the user for the presence of repeatable patterns that are unique to an individual. Users may be prompted with a rhythm to emulate by a rhythm guidance presenter. The presentation of the rhythm enables faster learning and emulation by keyboard users.
    Type: Application
    Filed: June 4, 2007
    Publication date: February 7, 2008
    Inventor: Steven Bender
  • Publication number: 20080028232
    Abstract: A user recognition and identification system and method to identify keyboard users. Key text is evaluated against previously recorded keystrokes by the user for the presence of repeatable patterns that are unique to an individual. Rhythms associated with passwords are screened compared to a database of banned rhythms.
    Type: Application
    Filed: June 4, 2007
    Publication date: January 31, 2008
    Inventor: Steven Bender
  • Publication number: 20080028231
    Abstract: A user recognition and identification system and method to identify keyboard users. Key text is evaluated against previously recorded keystrokes by the user for the presence of repeatable patterns that are unique to an individual. User profiles are updated as their repeatable patterns slowly change over time.
    Type: Application
    Filed: June 4, 2007
    Publication date: January 31, 2008
    Inventor: Steven Bender
  • Publication number: 20070162763
    Abstract: A user recognition and identification system and method is presented in which text entered by a user at a keyboard is evaluated against previously recorded keystrokes by the user for the presence of repeatable patterns that are unique to an individual.
    Type: Application
    Filed: March 6, 2007
    Publication date: July 12, 2007
    Inventors: Steven Bender, Howard Postley
  • Patent number: 7141581
    Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
    Type: Grant
    Filed: August 12, 2003
    Date of Patent: November 28, 2006
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Steven Bender, Dana Hu-Lowe, David Ray Shalinsky
  • Publication number: 20050197492
    Abstract: Polypeptides containing the kinase domain of a VEGFR are described. Also described are crystal structures of these polypeptides, including the crystal structures of VEGFR2KD:ligand complexes. The atomic coordinates derived from the crystal structures provide a three-dimensional description of the ligand-binding pocket of the kinase domain useful in drug discovery and design for the identification and design of modulators of kinase activity.
    Type: Application
    Filed: April 15, 2004
    Publication date: September 8, 2005
    Inventors: Steven Bender, Robert Kania, Michele McTigue, Cynthia Palmer, Chris Pinko, John Wickersham
  • Publication number: 20050124662
    Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
    Type: Application
    Filed: November 18, 2004
    Publication date: June 9, 2005
    Inventors: Robert Kania, Steven Bender, Allen Borchardt, Stephan Cripps, Cynthia Louise Palmer, Anna Maria Tempczyk-Russell, Michael Varney, Michael Raymond Collins
  • Publication number: 20050038097
    Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
    Type: Application
    Filed: August 12, 2003
    Publication date: February 17, 2005
    Inventors: Steven Bender, Donald Skalitzky, Dana Hu-Lowe
  • Patent number: 5450316
    Abstract: A cryogenic vacuum pump includes, in an integral assembly, temperature sensors and heaters associated with the first and second stages of the cryopumping array, a roughing valve and a purge valve. An electronic module removably coupled in the assembly responds to all sensors and controls all operations of the cryopump including regeneration thereof. System parameters are stored in a nonvolatile memory in the module. Included in the regeneration procedures are an auto-zero of the pressure gauge, heating of the array throughout rough pumping, and a change in pressure rate test to determine stall in rough pumping. The electronic module also restarts the system after power failure, limits use of a pressure gauge to safe conditions, provides warnings before allowing opening of the valves while the cryopump is operating and stores sensor calibration information. Control through a control pad on the pump may be limited by a password requirement. Password override is also provided.
    Type: Grant
    Filed: June 2, 1994
    Date of Patent: September 12, 1995
    Assignee: Helix Technology Corporation
    Inventors: Peter W. Gaudet, Donald A. Olsen, Steven A. Bender
  • Patent number: 5157928
    Abstract: A cryogenic vacuum pump includes, in an integral assembly, temperature sensors and heaters associated with the first and second stages of the cryopumping array, a roughing valve and a purge valve. An electronic module removably coupled in the assembly responds to all sensors and controls all operations of the cryopump including regeneration thereof. System parameters are stored in a nonvolatile memory in the module. Included in the regeneration procedures are an auto-zero of the pressure gauge, heating of the array throughout rough pumping, and a change in pressure rate test to determine stall in rough pumping. The electronic module also restarts the system after power failure, limits use of a pressure gauge to safe conditions, provides warnings before allowing opening of the valves while the cryopump is operating and stores sensor calibration information. Control through a control pad on the pump may be limited by a password requirement. Password override is also provided.
    Type: Grant
    Filed: May 20, 1991
    Date of Patent: October 27, 1992
    Assignee: Helix Technology Corporation
    Inventors: Peter W. Gaudet, Donald A. Olsen, Michael J. Eacobacci, John T. Harvell, Robert J. Lepofsky, David E. Roche, Steven A. Bender
  • Patent number: 4918930
    Abstract: A cryogenic vacuum pump includes, in an integral assembly, temperature sensors and heaters associated with the first and second stages of the cryopumping array, a roughing valve and a purge valve. An electronic module removably coupled in the assembly responds to all sensors and controls all operations of the cryopump including regeneration thereof. System parameters are stored in a nonvolatile memory in the module. Included in the regeneration procedures are an auto-zero of the pressure gauge, heating of the array throughout rough pumping, and a change in pressure rate test to determine stall in rough pumping. The electronic module also restarts the system after power failure, limits use of a pressure gauge to safe conditions, provides warnings before allowing opening of the valves while the cryopump is operating and stores sensor calibration information. Control through a control pad on the pump may be limited by a password requirement. Password override is also provided.
    Type: Grant
    Filed: September 13, 1988
    Date of Patent: April 24, 1990
    Assignee: Helix Technology Corporation
    Inventors: Peter W. Gaudet, Donald A. Olsen, Michael J. Eacobacci, John T. Harvell, Robert J. Lepofsky, David E. Roche, Steven A. Bender